Keep God Weird

Women who smoke are no more than likely to develop lung malignant neoplastic disease than men, United States research workers have got concluded.

There had been at odds grounds on women's risk, but the National Cancer Institute survey of over 450,000 people establish no grammatical gender difference.

The survey published in Lancet Arch Oncology establish a difference of lone 0.9% between the hazard for work force and that for women.

The most recent United Kingdom statistics demo that in 2006, 23% of work force and 21% of women were coffin nail smokers.

Lung malignant neoplastic disease kills around 30,000 people a twelvemonth in the UK.

'Vigorous attempts needed'

The research workers analysed information on smoke habits, diet, exercising and alcoholic beverage usage for 279,214 work force and 184,623 women aged between 50 and 71 life in eight United States states.

They then looked at lung malignant neoplastic disease rates.

The difference in hazard for women and work force who smoked was just 0.9%.

Men and women who smoke more than than two battalions per twenty-four hours were about 50 modern times more likely to develop lung malignant neoplastic disease than people who had never smoked.

The team, led by Dr Neal Freedman, said their survey benefited from its size, giving dependable determinations

They conclude: "Our determinations propose that women are not more than susceptible than work force to the carcinogenic personal effects of coffin nail smoke in the lung.

"Vigorous attempts should go on to be directed at eliminating smoke in both sexes."

Andy McEwen, helper manager of baccy surveys at Cancer Research UK's Health Behavior Research Centre, said: "Smoking have a annihilating consequence on the wellness of people trapped by their baccy addiction.

"The hazard of a smoker, male or female, developing lung malignant neoplastic disease is 15 modern times greater than that of a non-smoker and smoke goes on to be the greatest preventable cause of decease for work force and women."

"Smoking business relationships for the huge bulk of lawsuits of lung malignant neoplastic disease worldwide.

"More have to be done to assist all tobacco users to discontinue if we are to forestall future deceases from lung cancer."

Researchers hope that a protein establish in the bowels could take to the find of a vaccine for colon cancer, Reuters reported Tuesday.

A survey published in the Diary of the National Cancer Institute elaborate how mice were immunized with the protein and subsequently contaminated with colon tumors.

These mice had fewer tumours spreading to the lung and liver than usual. Unvaccinated animate beings had an norm of 30 new tumours in the lungs and liver, compared to the vaccinated mice that had three new tumors, research workers said.

The vaccinated mice also lived longer, the research workers wrote.

Colon malignant neoplastic disease impacts 1.2 million people in the human race each twelvemonth and kills 130,000.

Adam Snook and Dr. George C. Scott Waldman of Seth Thomas Thomas Jefferson University in City Of Brotherly Love wanted to look at colon malignant neoplastic disease because the intestinal lining — a mucosal country — is protected from much of the immune system activity.

Some proteins from these immune-protected sites are active on tumour cells, they said.

Snook and Waldman looked specifically at guanylyl Degree Centigrade protein, or GCC protein, which is normally only active in the intestinal lining and in spreading colorectal malignant neoplastic disease cells.

Cancers of the caput and neck, lung, breast, vagina and vesica also get in the mucosa, so this attack could also work for them, they said.

Children in the Northeast are more
likely to be diagnosed with cancer, especially tumours of the
immune system called lymphoma, according to the first U.S. study
identifying regional differences in the disease.

About 179 malignant neoplastic disease lawsuits were identified per million children
in northeasterly states, compared with 165 lawsuits in the Midwest
and Occident and 159 in the South, authorities men of science said in a
study reported today in the diary .

Cancer do in U.S. children under age 16
than any other disease, according to the National Cancer
Institute. Although decease rates are last in the Northeast,
mortality alone isn't a good measure, the study's writers said. New treatments are allowing most patients to dwell longer.

''Our research determinations may be utile for prioritizing
childhood malignant neoplastic disease research and control necessitates in footing of these
demographic and geographical variations,'' research workers from the
in Capital Of Georgia said in
the study.

The research workers didn't offer any theories for the higher
rate of diagnosed lawsuits in the Northeast.

The survey identified 36,446 lawsuits of malignant neoplastic disease in children age
19 and little that were reported from 2001 to 2003 to statewide
registries run by the CDC and the malignant neoplastic disease institute. The data
covered about 90 percentage of the population after seven states
whose figs didn't ran into quality criteria were excluded. Population-based rates were calculated from 2000 Census figures.

Leukemia Most Park

Leukemia was the most common paediatric malignant neoplastic disease diagnosis,
consistent with earlier studies, accounting for 26 percentage of
cases. About 18 percentage involved neoplasms, or abnormal cell
growth, in the cardinal nervous system, and 15 percentage were
lymphoma.

Lymphoma and cardinal nervous system tumors were more
common in children from the Northeast, where information from all
states was included. The charge per unit of leukaemia diagnoses was highest
in the West, possibly linked to a bunch of lawsuits under
investigation in Nevada, the research workers said.

The Northeast part includes New York, New
Jersey, Pennsylvania, Connecticut, Maine, Massachusetts, New
Hampshire, Rhode Island and Vermont.

To reach the newsman on this story:
in American Capital at
.